CEBDS is pleased to announce Novo Nordisk as its newest member. A leading global healthcare company, founded in 1923 and headquartered in Denmark, Novo Nordisk works to combat serious chronic diseases such as diabetes, obesity, endocrine disorders, and rare blood disorders.
With the purpose of driving change to overcome these conditions, the company leads scientific advancements, expands access to medicines, and invests in prevention and care initiatives, contributing to more resilient and sustainable health systems. Its actions directly address contemporary social and environmental challenges, especially regarding health promotion and the generation of long-term positive impact.
CEBDS connects business groups interested in driving the transition to a sustainable future. Will you be part of the change?
